This study examines postoperative outcomes and recovery predictors in circumcision patients with balanoposthitis, focusing on differences between diabetic and non-diabetic individuals, and those with or without taking sodium-glucose cotransporter 2 inhibitors (SGLT2i). While circumcision is typically straightforward, certain patients, particularly those with diabetes, may experience delayed wound healing and extended recovery due to glycosuria, causing increased stress.

The study included male patients over 18 who underwent circumcision. Demographic data such as age, BMI, comorbidities, and preoperative lab results were collected, along with information on follow-up duration and outpatient visits post-surgery. Independent t-tests and chi-square tests compared diabetic and non-diabetic patients, while logistic regression identified predictors for extended postoperative recovery. Statistical significance was set at p<0.05.

Out of 194 patients, 61 had diabetes. Results showed that diabetic patients had significantly higher serum fasting glucose (p<0.001), longer follow-up periods (33.5±36.7 vs. 20.5±21.8 days, p=0.002), and more follow-up visits (2.3±1.8 vs. 1.8±1.3 visits, p=0.049) compared to non-diabetics. Extended postoperative follow-up, defined as more than three clinic visits, was associated with diabetes (p=0.184, OR=1.77), taking SGLT2i (p=0.04, OR=2.73), glycosuria (p=0.038, OR=2.63), and hypertension (p=0.003, OR=3.87) on univariate analysis. Multivariate analysis identified hypertension as a significant predictor of prolonged postoperative follow-up.

In conclusion, diabetic patients, especially those with glycosuria, required more postoperative follow-up and outpatient visits. Optimizing preoperative blood glucose and blood pressure control is essential for improving surgical outcomes in diabetic patients undergoing circumcision. This approach could reduce patient stress, enhance recovery, and alleviate the strain on healthcare resources.